Multiple Sclerosis Clinical Trials
Sutter Health participates in clinical trials related to Multiple Sclerosis throughout their Northern California facilities. See the listing below for an overview of current trials, including contact information. For some trials, more detailed information can be found via the title link to ClinicalTrials.gov.
Title: A Phase II, Randomized, Double-Blind, Parallel-group, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Abatacept in Adults with Relapsing-remitting Multiple Sclerosis (National Institute of Allergy and Infectious Diseases) Opens in a new window
Description: The ACCLAIM study is testing whether the medication "abatacept" can be of benefit to patients with relapsing-remitting multiple sclerosis. Although abatacept is an investigational medication for MS, it is not a new drug - it has been approved by the FDA to treat rheumatoid arthritis.
Investigator: Joanna Cooper, MD
Status: Closed to enrollment
Location: Alta Bates Summit Medical Center
Contact: Bethany Wexler
510 204-1608 Email: WexlerB@sutterhealth.org
> See All Neurology Clinical Trials by Condition